Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yihong Wan

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Trends in Pharmacological Sciences|May 13, 2015
New therapeutic targets for cancer bone metastasisJing Y Krzeszinski, Yihong Wan
Current Osteoporosis Reports|July 29, 2016
MicroRNA Exert Macro Effects on Cancer Bone MetastasisScott R Baier, Yihong Wan
Nature Medicine|November 9, 2016
Reply to "PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation"Ronald M Evans, Yihong Wan
Recent Progress in Hormone Research|June 11, 2003
Overlapping but distinct profiles of gene expression elicited by glucocorticoids and progestinsYihong Wan, Steven K Nordeen
Journal of Molecular Endocrinology|October 24, 2009
Rosiglitazone activation of PPARgamma suppresses fractalkine signalingYihong Wan, Ronald M Evans
Molecular Endocrinology (Baltimore, Md.)|June 1, 2002
Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cellsYihong Wan, Steven K Nordeen
Seminars in Cell & Developmental Biology|October 21, 2017
Milk lipid regulation at the maternal-offspring interfaceDengbao Yang, HoangDinh Huynh, Yihong Wan
Cancer Research|August 26, 2021
Fam20C Regulates Bone Resorption and Breast Cancer Bone Metastasis through Osteopontin and BMP4Hao Zuo, Dengbao Yang, Yihong Wan
Molecular Endocrinology (Baltimore, Md.)|December 31, 2014
Minireview: nuclear receptor regulation of osteoclast and bone remodelingZixue Jin, Xiaoxiao Li, Yihong Wan
Cell Reports|June 8, 2017
mTOR Inhibition Subdues Milk Disorder Caused by Maternal VLDLR LossHoangDinh Huynh, Wei Wei, Yihong Wan
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Trends in Pharmacological Sciences|May 13, 2015
New therapeutic targets for cancer bone metastasisJing Y Krzeszinski, Yihong Wan
Current Osteoporosis Reports|July 29, 2016
MicroRNA Exert Macro Effects on Cancer Bone MetastasisScott R Baier, Yihong Wan
Nature Medicine|November 9, 2016
Reply to "PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation"Ronald M Evans, Yihong Wan
Recent Progress in Hormone Research|June 11, 2003
Overlapping but distinct profiles of gene expression elicited by glucocorticoids and progestinsYihong Wan, Steven K Nordeen
Journal of Molecular Endocrinology|October 24, 2009
Rosiglitazone activation of PPARgamma suppresses fractalkine signalingYihong Wan, Ronald M Evans
Molecular Endocrinology (Baltimore, Md.)|June 1, 2002
Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cellsYihong Wan, Steven K Nordeen
Seminars in Cell & Developmental Biology|October 21, 2017
Milk lipid regulation at the maternal-offspring interfaceDengbao Yang, HoangDinh Huynh, Yihong Wan
Cancer Research|August 26, 2021
Fam20C Regulates Bone Resorption and Breast Cancer Bone Metastasis through Osteopontin and BMP4Hao Zuo, Dengbao Yang, Yihong Wan
Molecular Endocrinology (Baltimore, Md.)|December 31, 2014
Minireview: nuclear receptor regulation of osteoclast and bone remodelingZixue Jin, Xiaoxiao Li, Yihong Wan
Cell Reports|June 8, 2017
mTOR Inhibition Subdues Milk Disorder Caused by Maternal VLDLR LossHoangDinh Huynh, Wei Wei, Yihong Wan
Pageof 7